Analyst Ratings for CME Group (CME) [Buys]
CME Rating Summary
CME Price Target Summary
- Highest: $250.00 (Piper Sandler)
- Lowest: $173.00 (Rosenblatt)
- Average: $212.29
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$212.29 (+4.1%)
* Over Last 12-Mos
Rating Score: 4.6 / 10
Percentile Rank: 46%
Avg. $ Target:
$212.29 (+4.1%)
* Over Last 12-Mos
Rating Score: 4.6 / 10
Percentile Rank: 46%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/28/2023 | Barclays » Updated 7/27/2023 |
Benjamin Budish | New Coverage | Overweight (N/A) |
230.00 (215.00) |
178.89 (203.85) |
13.95% | Details |
| 1/5/2023 | Credit Suisse » Updated 4/20/2023 |
Gautam Sawant | Upgrade | Outperform (Neutral) |
212.00 (207.00) |
168.95 (203.85) |
20.66% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
